GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » General Biologicals Corp (ROCO:4117) » Definitions » Pretax Margin %

General Biologicals (ROCO:4117) Pretax Margin % : -95.23% (As of Jun. 2024)


View and export this data going back to 2002. Start your Free Trial

What is General Biologicals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. General Biologicals's Pre-Tax Income for the six months ended in Jun. 2024 was NT$-106.0 Mil. General Biologicals's Revenue for the six months ended in Jun. 2024 was NT$111.3 Mil. Therefore, General Biologicals's pretax margin for the quarter that ended in Jun. 2024 was -95.23%.

The historical rank and industry rank for General Biologicals's Pretax Margin % or its related term are showing as below:

ROCO:4117' s Pretax Margin % Range Over the Past 10 Years
Min: -83.18   Med: -22.24   Max: 10.15
Current: -83.18


ROCO:4117's Pretax Margin % is ranked worse than
88.31% of 975 companies
in the Drug Manufacturers industry
Industry Median: 5.98 vs ROCO:4117: -83.18

General Biologicals Pretax Margin % Historical Data

The historical data trend for General Biologicals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

General Biologicals Pretax Margin % Chart

General Biologicals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.29 10.15 7.00 -12.45 -70.88

General Biologicals Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.31 -48.25 -68.85 -72.96 -95.23

Competitive Comparison of General Biologicals's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, General Biologicals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


General Biologicals's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, General Biologicals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where General Biologicals's Pretax Margin % falls into.


;
;

General Biologicals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

General Biologicals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-187.718/264.825
=-70.88 %

General Biologicals's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-105.962/111.275
=-95.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


General Biologicals  (ROCO:4117) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


General Biologicals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of General Biologicals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


General Biologicals Business Description

Traded in Other Exchanges
N/A
Address
No-6, Innovation First Road, Hsinchu Science Park, Hsinchu, TWN, 300092
General Biologicals Corp is a developer and manufacturer of vitro diagnostic devices in Taiwan. It offers research development, marketing and servicing of products and solutions for hospitals, medical laboratories, blood banks, and research and industry. Its products include Anti-HDV, HIV Ag-Ab COMB, Anti-HBs, and many others.

General Biologicals Headlines

No Headlines